Protara Therapeutics
IPOPublic · New York, United States · $45.0M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Business Model
- B2B
- Website
- protaratx.com
- Total Funding
- $45.0M
- Last Round
- $45.0M Private EquityJan 2022
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company developing transformative therapies for cancer and rare diseases.
Summary
Protara Therapeutics is a Biotech company based in New York, United States. It has raised $45.0M in total across 1 round, most recently a $45.0M Private Equity round in Jan 2022. Investors include Armistice Capital and Boxer Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.